S. Grebhardt

发表

Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy.

W. Haefeli, Dirk Theile, J. Weiss, 2009, Biochemical pharmacology.

Impact of S100A8/A9 Expression on Prostate Cancer Progression In Vitro and In Vivo

F. Bestvater, D. Mayer, M. Hershfinkel, 2014, Journal of cellular physiology.

Hypoxia and HIF‐1 increase S100A8 and S100A9 expression in prostate cancer

C. Veltkamp, D. Mayer, P. Ströbel, 2012, International journal of cancer.

Final Effectiveness and Safety Results of NABUCCO: Real‐World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab‐Paclitaxel

C. Salat, A. Nusch, U. Söling, 2018, Clinical breast cancer.

Prostaglandin E2 stimulates S100A8 expression by activating protein kinase A and CCAAT/enhancer-binding-protein-beta in prostate cancer cells.

Jiandang Shi, D. Mayer, Ju Zhang, 2012, The international journal of biochemistry & cell biology.

Janus kinase 2--a novel negative regulator of estrogen receptor α function.

D. Mayer, S. Grebhardt, N. Gupta, 2012, Cellular signalling.

Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR

H. Eschenburg, C. Gessner, A. Kretzschmar, 2022, Current medical research and opinion.

Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients

G. Egerer, M. Metz, A. Lorenz, 2021, Supportive Care in Cancer.

Prophylaxis of chemotherapy‐induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non‐Hodgkin lymphoma (NADIR study)

H. Hurtz, D. Reichert, H. Schulz, 2018, European journal of haematology.

Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in 2489 cancer patients: final results from the non-interventional study NADIR

H. Schulz, C. Kurbacher, K. Potthoff, 2019, Current medical research and opinion.

β-Catenin Is a Positive Regulator of Estrogen Receptor-α Function in Breast Cancer Cells

Fee Schmitt, D. Mayer, S. Grebhardt, 2011, Cancers.

Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non‐interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials

H. Eschenburg, W. Knauf, T. Dechow, 2021, European journal of haematology.